SEC Company Response from Compass Therapeutics, (CMPX) — Jan 5, 2026
Compass Therapeutics, Inc.
Date: Jan. 5, 2026 · CIK: 0001738021 · Accession: 0001193125-26-001593
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292491
Letter
Re: Compass Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333-292491) Acceleration Request: Requested Date: January 7, 2026 Requested Time: 10:00 A.M. Eastern Time Dear Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Compass Therapeutics, Inc. (the “Company”) hereby requests that the Registration Statement on Form S-3 (File No. 333-292491) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
COMPASS THERAPEUTICS, INC. 80 GUEST STREET, SUITE 601 BOSTON, MASSACHUSETTS 02135 VIA EDGAR January 5, 2026 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549
Sincerely,
COMPASS THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP COMPASS THERAPEUTICS, INC. 80 GUEST STREET, SUITE 601 BOSTON, MASSACHUSETTS 02135 VIA EDGAR January 5, 2026 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Compass Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333-292491) Acceleration Request: Requested Date: January 7, 2026 Requested Time: 10:00 A.M. Eastern Time Dear Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Compass Therapeutics, Inc. (the “Company”) hereby requests that the Registration Statement on Form S-3 (File No. 333-292491) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable. Sincerely, COMPASS THERAPEUTICS, INC. /s/ Barry Shin Barry Shin Chief Financial Officer